Pacifico Biolabs
PrivateLast Round
Series A
May 27, 2026
Total Funding Raised
$12.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pacifico Biolabs operates in Consumer & Commerce and is based in Berlin. Its latest recorded funding round was a Series A round in May 2026.
Pacifico Biolabs is a biotechnology company that develops sustainable and nutritious alternatives to traditional fish and meat products using a proprietary biomass fermentation process.
Sector
Consumer & Commerce
Verticals
Biotechnology, Sustainable Materials, Circular Economy
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pacifico Biolabs Comparables
Compare Pacifico Biolabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Koralo | 83% | |
| Revo Foods | 80% | |
| KULT FARM | 80% |
For institutional investors. Book with your work email.
Pacifico Biolabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2026 | ||||
| Grant | Sep 16, 2025 | ||||
| Pre Seed | Feb 16, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pacifico Biolabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CFH Management | Series A |
| TGFS Technologiegründerfonds Sachsen | Series A |
| Sprout & About Ventures | Pre Seed, Series A |
| Exceptional Ventures | Pre Seed |
| FoodLabs | Series A, Pre Seed |
| Stray Dog Capital | Series A |
| Simon Capital | Series A, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 284% MoM, reaching 2.8K.
- Jul 13, 2026
Open roles increased to 11, representing 48% of headcount.
For institutional investors. Book with your work email.
Pacifico Biolabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pacifico Biolabs's valuation, stock price, and market status.
Is Pacifico Biolabs a public or private company?
Pacifico Biolabs is a private company.
What is the current stock price of Pacifico Biolabs?
Pacifico Biolabs is a private company, so its shares have no public market price. Caplight tracks Pacifico Biolabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pacifico Biolabs worth (valuation)?
Valuation information for Pacifico Biolabs is not publicly available.
Can I buy Pacifico Biolabs stock?
Pacifico Biolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pacifico Biolabs's last funding round?
Pacifico Biolabs's most recent funding round was Series A on May 27, 2026.
Who are the main investors in Pacifico Biolabs?
Key investors in Pacifico Biolabs include FoodLabs, Simon Capital.
Will Pacifico Biolabs IPO soon?
No public IPO plans have been announced for Pacifico Biolabs.
How can I track Pacifico Biolabs secondary market activity?
Caplight tracks bids, offers, and trades in Pacifico Biolabs's shares on secondary markets.